Medtronic received FDA 510(k) clearance for its Accurian RF ablation platform, which conducts radiofrequency ablation of nerve tissues.
Three things to know:
1. Radiofrequency ablation is a minimally invasive procedure in which radio wave-produced current heats up a small area of nerve tissue to prevent it from sending pain signals.
2. The Accurian system features proprietary hardware and quad core processing with software for power and temperature control in order to lead to consistent lesion formation.
3. The Accurian RF ablation platform is designed for standard, pulsed and enhanced procedures using internally-cooled probes to create a range of lesion shapes, sizes, and volumes. It has independent channel control and chip-enhanced probes for easy on-screen identification, as well as smart features such as downloadable procedure reports to support procedural efficiency.